MedTrace Logo

Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic

NCT04400877 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7795

Last updated 2021-11-18

No results posted yet for this study

Summary

The purpose of this study is to investigate the prevalence of venous thromboembolism in a regional health care system (Region Östergötland, Sweden) before and during the SARS-COV-2 pandemic. In a retrospective observational study, we will review patient data, diagnostic data and treatment data over a three-month period since the onset of the SARS-COV-2 pandemic. This data will be compared with data from the corresponding time frame during the years 2015 to 2019.

Conditions

Interventions

DIAGNOSTIC_TEST

Diagnostic examination for venous thromboembolism

Patients who have done a diagnostic examination for suspected VTE (pulmonary embolism och deep venous thrombosis) within the health care system of Region Östergötland. Patients without matching diagnostic examination but with a new diagnosis of pulmonary embolism or deep venous thrombosis during the same time periods will also be taking into account.

Sponsors & Collaborators

  • University Hospital, Linkoeping

    lead OTHER

Principal Investigators

  • Jens Wretborn, MD · Emergency Department, University Hospital Linköping, Sweden

  • Patrik Benjaminsson Nyberg, PhD · Emergency Department, University Hospital Linköping, Sweden

  • Matthias Jörg, MD · Emergency Department, University Hospital Linköping, Sweden

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-08
Primary Completion
2020-07-30
Completion
2020-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04400877 on ClinicalTrials.gov